Cyclerion Therapeutics | DEFA14A: Others
Cyclerion Therapeutics | DEF 14A: Definitive information statements
Cyclerion Therapeutics | 8-K: Current report
Cyclerion Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer CHICKO RHONDA M.
Cyclerion Therapeutics | 10-K: Annual report
Cyclerion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Tyndall Capital Partners, L.P.(6.7%)
Cyclerion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(5.7%),Invus Public Equities Advisors, LLC(5.7%), etc.
Cyclerion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(6.660%),Abigail P. Johnson(6.660%)
Cyclerion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hecht Peter M
Cyclerion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Graul Regina Margaret
Cyclerion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Slate Path Capital LP(14.6%),David Greenspan(14.6%)
Cyclerion Therapeutics | UPLOAD: Others
Cyclerion Therapeutics | CORRESP: CORRESP
Cyclerion Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Katabi Dina
Cyclerion Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Higgins Michael J
Cyclerion Therapeutics | 3/A: Initial statement of beneficial ownership of securities (Amendment)-President Graul Regina Margaret
Cyclerion Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Cyclerion Therapeutics | 8-K: Current report
Cyclerion Therapeutics | 3: Initial statement of beneficial ownership of securities-President Graul Regina Margaret
Cyclerion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MCGUIRE TERRANCE
No Data